Retinal probe market seen reaching $1.51 billion by 2030

The retinal probe market is projected to grow from $1.02 billion in 2026 to $1.51 billion by 2030, driven by rising retinal disease cases, more vitreoretinal surgeries and wider use of minimally invasive tools. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Retinal probes are used in delicate vitreoretinal surgeries to inspect, manipulate, illuminate, coagulate or treat the retina. - Demand is rising as more patients need treatment for diabetic retinopathy, retinal detachment and other retinal disorders that can lead to vision loss. - Growth in the market reflects broader spending on ophthalmic surgery tools and specialized eye care.

What happened: - The retinal probe market is expected to increase from $0.92 billion in 2025 to $1.02 billion in 2026. - The market is forecast to reach $1.51 billion by 2030. - The report projects a 10.8% CAGR from 2025 to 2026 and a 10.4% CAGR through 2030. - The Business Research Company published the forecast in its Retinal Probe Global Market Report 2026. - The report was released Sept. 23, 2026.

The details: - Historic growth has been driven by rising diabetic retinopathy and retinal detachment cases, higher volumes of vitreoretinal surgeries, advances in microsurgical techniques and broader access to specialized ophthalmic care. - Future growth is expected to come from preference for minimally invasive retinal interventions, wider adoption of microincision vitreoretomy systems, aging populations, more investment in ophthalmic surgical technologies and expansion of retina-specialty treatment centers. - Key product trends include ultra-thin microincision retinal probes, disposable probes for surgical sterility, high-gauge probes for precision, multifunctional probes for complex surgeries and advanced fiber optic lighting. - Retinal probes are used in repairing retinal detachments, managing diabetic retinopathy, treating macular holes and other vitreoretinal microsurgeries. - The instruments are designed for high accuracy and help surgeons perform intricate procedures with more control and safety. - The market report offers additional tools including market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics. - The report also includes key technology analysis and future trend coverage. - A free sample of the report is available here. - The full report is available here.

Between the lines: - The market forecast points to steady demand rather than a short-term spike, with aging populations and diabetes-linked eye disease creating a long runway for surgical tools. - Disposable and higher-gauge probes suggest the market is shifting toward precision, sterility and less invasive procedures. - North America held the largest market share in 2025 because of advanced healthcare infrastructure and early adoption of surgical technologies. - Asia-Pacific is expected to be the fastest-growing region as healthcare investment rises and specialized eye care expands in emerging economies. - Regional analysis in the report also covers South East Asia, Western and Eastern Europe, South America, the Middle East and Africa. - Welsh Government data from July 2025 showed more than 197,000 people were eligible for diabetic eye screening as of March 2025, up 1.7% from a year earlier. - Of more than 88,000 completed screenings, about 34.1% detected some level of diabetic retinopathy.

What's next: - The market’s next phase will likely be shaped by continued adoption of microincision systems and disposable instruments. - More investment in retina specialty centers and ophthalmic technologies should support the forecast through 2030. - Broader screening and diagnosis of diabetic eye disease may keep surgical demand elevated.

The bottom line: - Retinal probe makers are positioned for sustained growth as retinal disease treatment becomes more common, more precise and less invasive.